SF Healthcare Week: Soleno Therapeutics' Chairman & CEO Anish Bhatnager discusses the launch of its Prader-Willi syndrome therapy VYKAT XR
- Jan 14
- 1 min read
He describes the launch, physician and patient feedback, and responds in his own words to short seller criticism.















.png)

